Amphastar Pharmaceuticals, Inc.
$1.32B- Market cap
- $986.88M
- Debt
- +$619.71M
- Cash
- −$282.81M
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AMPH · current priceP/E 11.43x
$23.20Latest market snapshot
Implied fair value · at PSX's multiple
$48.00106.9% above market
2.03 AMPH EPS (TTM)×23.65x PSX P/E=$48.00
Market $23.20Implied $48.00
PSX · current priceP/E 23.65x
$255.13Latest market snapshot
Implied fair value · at AMPH's multiple
$123.3151.7% below market
10.79 PSX EPS (TTM)×11.43x AMPH P/E=$123.31
Market $255.13Implied $123.31